Viewing Study NCT06446323



Ignite Creation Date: 2024-06-16 @ 11:50 AM
Last Modification Date: 2024-10-26 @ 3:31 PM
Study NCT ID: NCT06446323
Status: COMPLETED
Last Update Posted: 2024-06-06
First Post: 2024-05-31

Brief Title: Comparison of Minimal Effective Dose of Sucrose for Pain Relief in Neonates After Minor Procedure
Sponsor: Rawalpindi Medical College
Organization: Rawalpindi Medical College

Study Overview

Official Title: Comparison of Minimal Effective Dose of Sucrose for Pain Relief in Neonates After Minor Procedure
Status: COMPLETED
Status Verified Date: 2024-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Type of Study Randomized Controlled Trial Aim To compare the effectiveness of two doses of sucrose solution for pain relief in neonates after minor procedures

Participants Tasks

Receive either 02 ml or 05 ml of sucrose solution Undergo minor procedures Pain intensity assessment using the Premature Infant Pain Profile PIPP

Comparison Groups

Researchers compared the effects of administering 02 ml and 05 ml doses of sucrose solution on post-procedural pain in neonates
Detailed Description: This study is a randomized controlled trial conducted at the Department of Pediatric Surgery Holy Family Hospital Rawalpindi from March 2023 to February 2024 It aims to compare the effectiveness of two different doses of sucrose solution 02 ml versus 05 ml for pain relief in neonates after minor procedures

Objective

To compare the outcome of 02 ml versus 05 ml sucrose solution for pain relief in neonates after minor procedures

Study Design

Randomized Controlled Trial

Study Place and Duration

Department of Pediatric Surgery Holy Family Hospital Rawalpindi March 2023 to February 2024

Participants and Methods

Total of 148 neonates enrolled who underwent minor procedures and were admitted to the neonatal intensive care unit

Randomly divided into two groups

Group I Administered 02 ml of sucrose solution Group II Administered 05 ml of sucrose solution Pain intensity measured using the Premature Infant Pain Profile PIPP Data analyzed using SPSS version 250

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None